• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Clin Neuropsychol . Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort

tetano

Editor, Senior Moderator
Arch Clin Neuropsychol


. 2022 Aug 9;acac068.
doi: 10.1093/arclin/acac068. Online ahead of print.
Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort


P Voruz[SUP] 1 2 3 [/SUP], I Jacot de Alcântara[SUP] 1 2 [/SUP], A Nuber-Champier[SUP] 1 [/SUP], A Cionca[SUP] 1 [/SUP], G Allali[SUP] 2 3 4 [/SUP], L Benzakour[SUP] 3 5 [/SUP], P H Lalive[SUP] 2 3 [/SUP], K-O Lövblad[SUP] 3 6 [/SUP], O Braillard[SUP] 7 [/SUP], M Nehme[SUP] 7 [/SUP], M Coen[SUP] 8 [/SUP], J Serratrice[SUP] 8 [/SUP], J-L Reny[SUP] 8 [/SUP], J Pugin[SUP] 3 9 [/SUP], I Guessous[SUP] 3 7 [/SUP], R Ptak[SUP] 3 10 [/SUP], B N Landis[SUP] 3 11 [/SUP], F Assal[SUP] 2 3 [/SUP], J A Péron[SUP] 1 2 [/SUP]



Affiliations

Abstract

Objective: Several studies have reported poor long-term neuropsychological performances in patients following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but none has yet considered the effect of administering multiple intercorrelated neuropsychological tests and assessed the frequency of cognitive deficits in a normative population. Our aim was therefore to assess the presence of cumulative neuropsychological deficits in an actual post-coronavirus disease of 2019 (COVID-19) comparison group versus one simulated using Monte-Carlo methods.
Method: Validated neuropsychological Monte-Carlo simulation methods were applied to scores from a battery of neuropsychological tests (memory, executive, attentional, perceptual, logical reasoning, language, and ideomotor praxis) administered to 121 patients who had had mild, moderate, or severe COVID-19 (mean age: 56.70 years; 32% women), 222 ± 43 days post-infection. The cumulative percentages of the three severity subgroups were compared with the results of a false discovery rate-corrected probability analysis based on normative data.
Results: The cumulative percentages of deficits in memory and executive functions among the severe and moderate patients were significantly higher than those estimated for the normative population. Moderate patients also had significantly more deficits in perception and logical reasoning. In contrast, the mild group did not have significantly more cumulative deficits.
Conclusions: Moderate and severe forms of COVID-19 cause greater long-term neuropsychological deficits than those that would be found in a normative population, reinforcing the hypothesis of long-term effects of SARS-CoV-2 on cognitive function, independent of the severity of the initial infection.

Keywords: Executive functions; Memory; Neuropsychology; Post-COVID-19 condition; Simulation.
 
Back
Top Bottom